• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Treatment of postmenopausal osteoporosis with daily parathyroid hormone plus calcitriol.

作者信息

Neer M, Slovik D M, Daly M, Potts T, Nussbaum S R

机构信息

Massachusetts General Hospital, Department of Medicine, Boston.

出版信息

Osteoporos Int. 1993;3 Suppl 1:204-5. doi: 10.1007/BF01621907.

DOI:10.1007/BF01621907
PMID:8461561
Abstract
摘要

相似文献

1
Treatment of postmenopausal osteoporosis with daily parathyroid hormone plus calcitriol.每日使用甲状旁腺激素联合骨化三醇治疗绝经后骨质疏松症。
Osteoporos Int. 1993;3 Suppl 1:204-5. doi: 10.1007/BF01621907.
2
[Parathyroid and bone. Role of parathyroid hormone in the treatment of osteoporosis].[甲状旁腺与骨骼。甲状旁腺激素在骨质疏松症治疗中的作用]
Clin Calcium. 2007 Dec;17(12):1823-9.
3
[Therapy of osteoporosis using the ADFR schedule (especially with parathyroid hormone and etidronate)].
Internist (Berl). 1991 Feb;32(2):76-9.
4
Combination treatment with estrogen and calcitriol in the prevention of age-related bone loss.雌激素与骨化三醇联合治疗预防年龄相关性骨质流失
J Clin Endocrinol Metab. 2001 Aug;86(8):3618-28. doi: 10.1210/jcem.86.8.7703.
5
A randomized controlled trial to compare the efficacy of cyclical parathyroid hormone versus cyclical parathyroid hormone and sequential calcitonin to improve bone mass in postmenopausal women with osteoporosis.一项随机对照试验，比较周期性甲状旁腺激素与周期性甲状旁腺激素联合序贯降钙素对改善绝经后骨质疏松症女性骨量的疗效。
J Clin Endocrinol Metab. 1997 Feb;82(2):620-8. doi: 10.1210/jcem.82.2.3762.
6
Combination and sequential therapy for osteoporosis.骨质疏松症的联合及序贯治疗
N Engl J Med. 2005 Aug 11;353(6):624-5. doi: 10.1056/NEJMe058154.
7
Daily and cyclic parathyroid hormone in women receiving alendronate.接受阿仑膦酸盐治疗的女性的每日及周期性甲状旁腺激素
N Engl J Med. 2005 Aug 11;353(6):566-75. doi: 10.1056/NEJMoa050157.
8
The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis.甲状旁腺激素和阿仑膦酸钠单独或联合应用对绝经后骨质疏松症的影响。
N Engl J Med. 2003 Sep 25;349(13):1207-15. doi: 10.1056/NEJMoa031975. Epub 2003 Sep 20.
9
PREOS NPS (Allelix/Nycomed).PREOS NPS（艾力克斯/奈科明公司）
Curr Opin Investig Drugs. 2005 Oct;6(10):1057-66.
10
ALX 111: ALX1-11, parathyroid hormone (1-84) - NPS Allelix, PREOS, PTH, recombinant human parathyroid hormone, rhPTH (1-84).ALX 111：ALX1 - 11、甲状旁腺激素（1 - 84） - NPS Allelix、PREOS、PTH、重组人甲状旁腺激素、rhPTH（1 - 84）
Drugs R D. 2003;4(4):231-5. doi: 10.2165/00126839-200304040-00003.

引用本文的文献

1
The Effect of Teriparatide on the Hip: A Literature Review.特立帕肽对髋部的影响：文献综述
Hip Pelvis. 2021 Jun;33(2):45-52. doi: 10.5371/hp.2021.33.2.45. Epub 2021 Jun 4.
2
Bone-targeting parathyroid hormone conjugates outperform unmodified PTH in the anabolic treatment of osteoporosis in rats.靶向骨的甲状旁腺激素缀合物在治疗大鼠骨质疏松症的合成代谢治疗中优于未修饰的 PTH。
Drug Deliv Transl Res. 2017 Aug;7(4):482-496. doi: 10.1007/s13346-017-0407-2.
3
Parathyroid hormone and its receptor gene polymorphisms: implications in osteoporosis and in fracture healing.

本文引用的文献

1
Parathyroid hormone stimulates the bone apposition rate independently of its resorptive action: differential effects of intermittent and continuous administration.甲状旁腺激素独立于其吸收作用刺激骨沉积率：间歇性和持续性给药的不同效应。
Endocrinology. 1982 Feb;110(2):506-12. doi: 10.1210/endo-110-2-506.
2
Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis: a multicentre trial.人甲状旁腺激素片段对绝经后骨质疏松症小梁骨的合成代谢作用：一项多中心试验。
Br Med J. 1980 Jun 7;280(6228):1340-4. doi: 10.1136/bmj.280.6228.1340.
3
Effects of two treatment regimes with synthetic human parathyroid hormone fragment on bone formation and the tissue balance of trabecular bone in greyhounds.
甲状旁腺激素及其受体基因多态性：对骨质疏松症和骨折愈合的影响
Rheumatol Int. 2016 Jan;36(1):1-6. doi: 10.1007/s00296-015-3319-9. Epub 2015 Jul 21.
4
The use of intermittent human parathyroid hormone as a treatment for osteoporosis.间歇性使用人甲状旁腺激素治疗骨质疏松症。
Curr Rheumatol Rep. 2004 Feb;6(1):49-58. doi: 10.1007/s11926-004-0083-3.
5
Parathyroid hormone treatment can reverse corticosteroid-induced osteoporosis. Results of a randomized controlled clinical trial.甲状旁腺激素治疗可逆转皮质类固醇诱导的骨质疏松症。一项随机对照临床试验的结果。
J Clin Invest. 1998 Oct 15;102(8):1627-33. doi: 10.1172/JCI3914.
6
Parathyroid hormone in the treatment of involutional osteoporosis: back to the future.甲状旁腺激素治疗绝经后骨质疏松症：回归未来。
Osteoporos Int. 1997;7 Suppl 3:S163-8. doi: 10.1007/BF03194365.
7
Stimulation of the growth of femoral trabecular bone in ovariectomized rats by the novel parathyroid hormone fragment, hPTH-(1-31)NH2 (Ostabolin).新型甲状旁腺激素片段hPTH-(1-31)NH2（奥司他丁）对去卵巢大鼠股骨小梁骨生长的刺激作用
Calcif Tissue Int. 1996 Feb;58(2):81-7. doi: 10.1007/BF02529728.
两种合成人甲状旁腺激素片段治疗方案对灵缇犬骨形成及小梁骨组织平衡的影响
Endocrinology. 1983 Mar;112(3):1000-6. doi: 10.1210/endo-112-3-1000.
4
Increased trabecular bone mass in rats treated with human synthetic parathyroid hormone.
Metab Bone Dis Relat Res. 1984;5(4):177-81. doi: 10.1016/0221-8747(84)90026-2.
5
Increase of whole-body calcium and skeletal mass in normal and osteoporotic adult rats treated with parathyroid hormone.
Clin Sci (Lond). 1982 Apr;62(4):389-96. doi: 10.1042/cs0620389.
6
Parathyroid hormone and experimental osteosclerosis.
Lancet. 1970 Jun 27;1(7661):1363-6. doi: 10.1016/s0140-6736(70)91271-7.
7
Restoration of spinal bone in osteoporotic men by treatment with human parathyroid hormone (1-34) and 1,25-dihydroxyvitamin D.通过用人甲状旁腺激素（1-34）和1,25-二羟基维生素D治疗恢复骨质疏松男性的脊柱骨
J Bone Miner Res. 1986 Aug;1(4):377-81. doi: 10.1002/jbmr.5650010411.
8
Biochemical responses to sequential human parathyroid hormone (1-38) and calcitonin in osteoporotic patients.骨质疏松症患者对序贯给予人甲状旁腺激素（1-38）和降钙素的生化反应。
Bone Miner. 1990 May;9(2):137-52. doi: 10.1016/0169-6009(90)90080-y.
9
The anabolic effects of human parathyroid hormone (hPTH) on rat vertebral body mass are also reflected in the quality of bone, assessed by biomechanical testing: a comparison study between hPTH-(1-34) and hPTH-(1-84).
Endocrinology. 1991 Jul;129(1):421-8. doi: 10.1210/endo-129-1-421.